MedPath

TVMR With the Innovalve System Trial - TWIST-BE TWIST-PILOT-BE

Not Applicable
Withdrawn
Conditions
Mitral Valve Regurgitation (Degenerative or Functional)
Registration Number
NCT05263375
Lead Sponsor
Innovalve Bio Medical Ltd.
Brief Summary

Study to evaluate the safety and performance of the Innovalve mitral valve replacement system

Detailed Description

Not available

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • Clinically significant, symptomatic mitral regurgitation
  • High risk for open-heart surgery
  • Meets anatomical criteria
Exclusion Criteria
  • Unsuitable anatomy
  • Patient is inoperable
  • EF <30%

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Number of patients with implant or delivery related serious adverse events at 30 days30 days

Number of patients with implant or delivery related serious adverse events at 30 days

Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.